OBAGI Prescription Acne Treatment System (CLENZIderm M.D.)
THIS PRODUCT HAS BEEN DISCONTINUED IN THE UK, AS OF 2026, AND IS NO LONGER AVAILABLE.
The Clenziderm Foaming cleanser, and pore therapy are still available to purchase individually, however, the Therapeutic lotion is no longer available - hence this treatment system is discontinued. You can find both the foaming cleanser, and the pore therapy, available on our webiste.
Any questions, please email us info@sebastianrose.co.uk
Thank you
OBAGI CLENZIderm M.D. System is a prescription-strength 3-step acne treatment program designed for moderate to severe acne. This medical-grade system combines prescription-active ingredients to treat existing breakouts, prevent new blemishes, and improve overall skin clarity.
The therapeutic system works synergistically to target acne-causing bacteria, reduce inflammation, unclog pores, and regulate sebum production. Clinically proven for oily and acne-prone skin types.
PRESCRIPTION-ONLY MEDICINE SYSTEM
This product requires:
✓ FREE medical consultation and skin assessment
✓ Qualified prescriber approval
✓ Identity verification
✓ Not suitable during pregnancy or breastfeeding
✓ Medical history review for contraindications
SYSTEM INCLUDES
Complete 3-step regimen with prescription-strength formulations designed to work together for optimal acne control and skin improvement.
BEST FOR
- Moderate to severe acne
- Oily, acne-prone skin
- Persistent breakouts
- Inflammatory acne
- Comedonal acne (blackheads/whiteheads)
- Post-inflammatory hyperpigmentation from acne
USAGE INSTRUCTIONS
Follow the complete 3-step system twice daily (morning and evening) as directed by your prescriber. Initial skin purging may occur during first 2-4 weeks of treatment. Sunscreen use is essential during treatment.
IMPORTANT SAFETY INFORMATION
May increase sun sensitivity. Avoid during pregnancy or breastfeeding. Inform prescriber of all current medications and skin conditions. Gradual introduction recommended to minimize irritation.
IMPORTANT: Consultation, medical assessment, and regulatory verification required before dispensing. Payment does not guarantee approval. This prescription treatment requires ongoing prescriber oversight.